Which of the following is given to treat thrombocytopenia secondary' to anti-cancer therapy and is known to stimulate progenitor megakaryocytes?
Ans. is 'b' i.e., Oprelvekin o Oprelvekin (1L-11) is used to prevent and treat thrombocytopenia.
Filgrastim
Oprelvekin
Erythropoietin
Anagrelide
Platelet Disorders